Males, n = 1514 | Metabolic syndrome | No metabolic syndrome | p |
---|---|---|---|
Subjects, n | 379 | 1135 | Â |
Age, years | 50 ± 11 | 44 ± 13 | < 0.001 |
Physical inactivity (n), % | (136) 36 | (488) 43 | 0.002 |
Current smoking (n), % | (174) 46 | (533) 47 | 0.81 |
Med Diet score (0–55) | 23.4 ± 6.1 | 24.5 ± 5.5 | 0.01 |
Hypertension (n), % | (242) 64 | (306) 27 | < 0.001 |
Hypercholesterolemia (n), % | (216) 57 | (420) 37 | < 0.001 |
Diabetes (n), % | (72) 19 | (45) 4 | < 0.001 |
Overweight (n), % | (208) 56 | (533) 47 | < 0.001 |
Obesity (n), % | (167) 44 | (136) 12 | < 0.001 |
Body mass index (kg/m2) | 29.8 ± 0.2 | 26.5 ± 0.1 | < 0.001 |
γ-GT (IU/L) | 28 ± 12 | 26 ± 14 | 0.24 |
AST (IU/L) | 27 ± 14 | 27 ± 11 | 0.98 |
ALT (IU/L) | 26 ± 17 | 23 ± 12 | 0.25 |
AST/ALT ratio | 1.11 ± 0.3 | 1,28 ± 0,48 | 0.01 |
Females, n = 1528 | Metabolic syndrome | No metabolic syndrome | p |
Subjects, n | 228 | 1300 | Â |
Age, years | 53 ± 14 | 43 ± 14 | < 0.001 |
Physical inactivity (n), % | (62) 27 | (520) 40 | < 0.001 |
Current smoking (n), % | (78) 34 | (520) 40 | 0.07 |
Med Diet score (0–55) | 24 ± 6.8 | 28.2 ± 7.2 | < 0.001 |
Hypertension (n), % | (128) 56 | (234) 18 | < 0.001 |
Hypercholesterolemia (n), % | (114) 50 | (442) 34 | < 0.001 |
Diabetes (n), % | (52) 23 | (39) 3 | < 0.001 |
Overweight (n), % | (87) 38 | (377) 29 | < 0.001 |
Obesity (n), % | (105) 46 | (130) 10 | < 0.001 |
Body mass index (kg/m2) | 29.8 ± 4.9 | 24.5 ± 4.3 | < 0.001 |
γ-GT (IU/L) | 21 ± 12 | 17 ± 13 | 0.02 |
AST (IU/L) | 23 ± 9 | 23 ± 11 | 0.76 |
ALT (IU/L) | 20 ± 12 | 18 ± 10 | 0.18 |
AST/ALT ratio | 1.26 ± 0.3 | 1.44 ± 0.6 | 0.018 |